Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2013 Sep;270(9):2465-72.
doi: 10.1007/s00405-013-2362-y. Epub 2013 Jan 31.

Tolerability and effects on quality of life of liposomal nasal spray treatment compared to nasal ointment containing dexpanthenol or isotonic NaCl spray in patients with rhinitis sicca

C Hahn  1 , M Böhm, S Allekotte, R Mösges
Affiliations
Observational Study

Tolerability and effects on quality of life of liposomal nasal spray treatment compared to nasal ointment containing dexpanthenol or isotonic NaCl spray in patients with rhinitis sicca

C Hahn et al. Eur Arch Otorhinolaryngol. 2013 Sep.

Abstract

This study aimed to investigate symptom reduction via the liposomal nasal spray LipoNasal (LN) in patients with rhinitis sicca. Tolerability and the impact on quality of life were also examined. The same parameters were established in parallel for treatment approaches with Bepanthen (BP) nasal ointment containing dexpanthenol and the Rhinomer (RH) nasal spray containing NaCl. This prospective, controlled, open-label observation study was a multicenter trial. 92 patients with rhinitis sicca were allocated to three arms according to their symptoms: LN: n = 33; BP: n = 32 and RH: n = 27. The study comprised three visits at an interval of 14 days. Efficacy was examined by the Rhinitis Sicca Symptom Score (RSSS) documented daily and at the visits based on an endoscopic evaluation. The nasal spray sensory scale was used to investigate the tolerability. Quality of life (QoL) was measured by means of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and the "Short Form 12" of the "Impact on Health-Related Quality of Life (HRQL)" questionnaire on general quality of life. Nasal symptoms improved significantly (p = 0.001) under all three treatment approaches, reflected by the reduction in the RSSS and the Endoscopy Sum Score. A comparison of the three groups showed that no therapy was significantly superior to any of the others (p = 0.410). The tolerability of all treatments was good. Concerning the nasal moisturization, LipoNasal was evaluated better than Bepanthen and Rhinomer. Quality of life improved in all groups, but not significantly. The results show good efficacy and tolerability of the liposomal nasal spray compared to generally recognized treatments of rhinitis sicca with dexpanthenol nasal ointment and NaCl nasal spray. LipoNasal therefore constitutes a good treatment for patients suffering from dry nose.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Comparison of the duration of action within the three groups
Fig. 2
Fig. 2
Development of RQLQ global score
See this image and copyright information in PMC

References

    1. Hildenbrand T, Weber RK, Brehmer D. Rhinitis sicca, dry nose and atrophic rhinitis: a review of the literature. Eur Arch Otorhinolaryngol. 2011;268(1):17–26. doi: 10.1007/s00405-010-1391-z. - DOI - PubMed
    1. Hilding A. Experimental surgery of the nose and sinuses: i. changes in the morphology of the epithelium following variations in ventilation. Arch Otolaryngol Head Neck Surg. 1932;16:9–18. doi: 10.1001/archotol.1932.00630040016002. - DOI
    1. Klöcker N, Verse T, Rudolph P. Die schleimhautprotektive Wirkung von Dexpanthenol in Nasensprays. Erste Ergebnisse zytotoxischer und zilientoxischer Versuche in vitro. (The protective effect of dexpanthenol in nasal sprays. First results of cytotoxic and ciliary-toxic studies in vitro) Laryngorhinootologie. 2003;82(3):177–182. doi: 10.1055/s-2003-38406. - DOI - PubMed
    1. Ebner F, Heller A, Rippke F, et al. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol. 2002;3(6):427–433. doi: 10.2165/00128071-200203060-00005. - DOI - PubMed
    1. Kehrl W, Sonnemann U. Dexpanthenol-Nasenspray als wirksames Therapieprinzip zur Behandlung der Rhinitis sicca anterior. (Dexpanthenol nasal spray as an effective therapeutic principle for treatment of rhinitis sicca anterior) Laryngorhinootologie. 1998;77(9):506–512. doi: 10.1055/s-2007-997014. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources